Membership CPD Pre-reg Portfolio
Search the register

Fitness to Practise Hearings

STATUTORY COMMITTEE PUBLIC HEARING

Hearings of the Pharmaceutical Society of Northern Ireland Statutory Committee are open to the public and are scheduled to be held at Society House, 73 University Street, Belfast, BT7 1HL. You should beware that part of a hearing may be held in private, for example, when discussing a registrant’s health. Dates and times may change at short notice so please check on 02890 326927 before travelling.

Contact:

Peter Hutchinson-Secretary to the Statutory Committee

Tel: 02890 326927

Email: peter.hutchinson@psni.org.uk

If you’re a member of the media please contact the press office before attending

Hearings 2020

STATUTORY COMMITTEE PUBLIC HEARING

Heather Trueick 

The Statutory Committee of the Pharmaceutical Society of NI will meet on 13 and 14 October 2020 to consider allegations of impairment in relation to the Registrant, Heather Trueick, Registration Number 2448 R.

Summary of allegations:

That the Registrant, as a director of Wynrose Limited, and holding the role of superintendent pharmacist for that company, and having effective control over the business:

  1. On or between 22nd July 2012 and 22nd September 2016, having taken on pre-registration trainees, failed to ensure that the business was organised or operated in such a way that the Pharmaceutical Society of Northern Ireland’s requirements and conditions for pre-registration training were adhered to and observed.
  2. On or between 22nd July 2012 and 22nd September 2016, managed the business in such a way that trainees were not placed with accredited tutors in accordance with the Standards for Pre-Registration Training (July 2012), adversely impacting the ability of the designated tutors to properly carry out their function.
  3. On or between 22nd July 2012 and 22nd September 2016, managed the business in such a way that trainees, tutors and the employer were not able to comply with the Standards for Pre-Registration Training (July 2012), thereby undermining the pre-registration training programme.
  4. On or between 22nd July 2012 and 22nd September 2016, actively assisted, facilitated and allowed the prescribed standards for pre-registration training to be breached.
  5. Fundamentally failed in her duty to Trainee A, in the supply and provision of a placement for the purposes of providing pre-registration training, causing harm to him and in particular that he was required to undertake additional training in order to validate his pre-registration training.
  6. Fundamentally failed in her duty to Trainee B, in the supply and provision of a placement for the purposes of providing pre-registration training, causing harm to him and in particular that he was required to undertake additional training in order to validate his pre-registration training.
  7. On and between 31st July 2014 and 11th May 2015, failed to properly or adequately respond to, or address, concerns expressed to the Registrant by Trainee C that Tutor A should have been working with him on a full time basis as tutor and that he was not.
  8. Knowing that the pre-registration training arrangements for Trainee C were not adequate and did not comply with the Standards for Pre-Registration Training (July 2012), the Registrant wrongly assured Trainee C that the arrangements were adequate and allowed the situation to continue.
  9. On and between 6th July 2015 and 22nd September 2016, failed to properly or adequately respond to, or address, concerns expressed to the Registrant, whether by Trainee D or Tutor B, about the pre-registration training arrangements for Trainee D.
  10. Knowing that the pre-registration training arrangements for Trainee D were not adequate and did not comply with the Standards for Pre-Registration Training (July 2012), the Registrant continued to place Trainee D in Campbell’s Pharmacy rather than McFadden’s Pharmacy as requested by his designated tutor, Tutor B , in breach of the Standards for Pre-Registration Training (July 2012).
  11. On and between 14th April 2019 and 1st May 2019, the Registrant failed as superintendent of Wynrose Limited to ensure that the Pharmacy Record at Rosetta Pharmacy was properly maintained pursuant to Section 72A(5) of the Medicines Act 1968.
  12. On 2nd May 2019, the Registrant caused, allowed or permitted prescription medication to be dispensed from Rosetta Pharmacy other than under the control and supervision of a pharmacist as the dispensing occurred at a point in time when the pharmacy notified as being closed due to the unavailability a pharmacist.
  13. On 24th May 2019, other than under the control and supervision of a pharmacist, the Registrant caused, allowed or permitted deliveries of medicines (namely and in particular controlled drugs and prescription only medication) to be received at Rosetta Pharmacy.
  14. The Society further alleges that the Registrant is in breach of selected principles and obligations of the Pharmaceutical Society of Northern Ireland’s Code of Conduct Ethics and Performance (2016) and the Pharmaceutical Society of Northern Ireland’s Code of Ethics (2009), by reason of misconduct.
  15. By the Registrant’s acts and / or omissions, it is alleged that she has:
  • created a risk to the safety of patients,
  • brought the profession into disrepute,
  • failed to maintain public trust and confidence in your profession
  • failed, on a professional basis, to observe the principles set out above, and
  • failed to demonstrate honesty, integrity and professionalism.

This hearing will convene remotely, using online technology, on Tuesday 13 October and Wednesday 14 October 2020. If a member of the public has an inquiry about this hearing they should contact the Secretary to the Statutory Committee: peter.hutchinson@psni.org.uk

This hearing was adjourned on Wednesday 14 October 2020 and will reconvene on Friday 16 October 2020, 09:30am.

Link to Statutory Committee determination

STATUTORY COMMITTEE PUBLIC HEARING 

Michelle McCorry

The Statutory Committee of the Pharmaceutical Society of NI will meet on 21 September 2020 to consider allegations of impairment in relation to the Registrant Michelle McCorry, Registration Number 3276 IP R.

Summary of allegations:

  1. On and between 17 September 2018 and 10 May 2019, the registrant’s professional performance was deficient, pursuant to Paragraph 4(1)(b) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976.

Particulars of deficient professional performance are as follows:

  • A review of 9 incident reports at Donaghadee Health Centre, Donaghadee relating to patients dealt with by the registrant revealed errors and competence issues;
  • A review of 63 patients dealt with by the registrant at Loughview Medical Centre, Kircubbin revealed 43 examples demonstrating errors and competence issues;
  • Potential or actual patient safety issues were identified;
  • Errors were detected with the registrant’s practice as a GP practice based pharmacist with such frequency and to such an extent that basic competencies expected of a practice based pharmacist were lacking. In particular, it is alleged that the registrant –
  • failed to adhere to the basic principles of medication reconciliation in accordance with training and guidance;
  • failed to adhere to a medicines reconciliation agreement between the registrant and the GP practice;
  • made basic errors in relation to the supply of medication and the provision of pharmaceutical services;
  • failed to display sufficient competence to practise as a practice based pharmacist; and
  • failed to report near misses and adverse incidents, as required.
  • Taken individually and collectively, the errors and competence issues detected have given rise to a cumulative concern about the registrant’s ability to practise safely and effectively as a pharmacist; and
  • Particular concerns are extant with respect to the registrant practising as a pharmacist within a GP practice based setting and offering services as an independent prescriber (IP).
  1. The Society further alleges that the Registrant is in breach of selected principles and obligations of the Pharmaceutical Society of Northern Ireland’s Code of Conduct Ethics and Performance (2016) by reason of deficient professional performance.
  2. By her deficient professional performance, it is alleged that the registrant has:
  • created a risk to the safety of patients;
  • brought the profession into disrepute;
  • failed to maintain public trust and confidence in her profession; and
  • failed, on a professional basis, to observe the principles set out above,

This hearing will convene remotely, using online technology, on Monday 21 September 2020. If a member of the public has an inquiry about this hearing they should contact the Secretary to the Statutory Committee:  peter.hutchinson@psni.org.uk

Link to Statutory Committee determination